NCT03751956View on ClinicalTrials.gov

A Study Evaluating the Mass Balance of [14C]HSK3486 Emulsion Injection in Healthy Adults.

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 6, 2019

Primary Completion Date

February 28, 2019

Study Completion Date

March 10, 2019

Conditions
AnesthesiaSedation
Interventions
DRUG

HSK3486

The subjects will receive an intravenous injection of 0.8 μCi/0.4 mg/kg of \[14C\]HSK3486 emulsion injection (i.e., a subject with the body weight of 60 kg is administered with a radiation dose of 48 μCi).

Trial Locations (1)

Unknown

the First Affilicated Hospital of Soochow University, Suzhou

All Listed Sponsors
lead

Sichuan Haisco Pharmaceutical Group Co., Ltd

INDUSTRY

NCT03751956 - A Study Evaluating the Mass Balance of [14C]HSK3486 Emulsion Injection in Healthy Adults. | Biotech Hunter | Biotech Hunter